2011 Anniversary Yearbook - EUFEPS today and history

More documents

Recommendations

Info

17. Sponsorship Recognition The core funding of EUFEPS is based on annual membership fees. The major part is provided by the EUFEPS Member Societies, the fee of which is related to the size of the Member Society. Currently, there are 24 Member Societies of EUFEPS, in 24 countries, including Israel and Turkey. In addition there are around 500 Individual Members of EUFEPS as well as 15 Member Institutions, comprising universities and research institutes. “Meetings and events”, meaning congresses, conferences, workshops and courses etc. is an additional source of income of EUFEPS, in many cases covering not only direct expenses and the administration and management of them, but also some of the development costs for future activities, including important and crucial meetings not bearing their own financial burden. In addition, EUFEPS initiated and participated (and still does) in EU funded projects, also covering their own costs and time spent, after approved application and reimbursements. Since 2007, a number of major European pharmaceutical companies provided significant sustained sponsorship for EUFEPS, in three-year cycles or year by year. This is gratefully acknowledged. It helped to, for example, keep and continuously run the permanent secretariat of EUFEPS, located in Stockholm, Sweden. Sustained sponsors were/are: AstraZeneca, Bayer Healthcare, GlaxoSmithKline, Novartis and Pfizer. In addition, many companies sponsored EUFEPS events, over the years, including those organised by EUFEPS Networks. For the future, even broader support of EUFEPS will be sought to build longer term financial stability – more members (societies, individuals and institutes), as well as small, medium and big companies, all for new significant initiatives and to better serve the pharmaceutical scientist community, e.g. towards a framework for continuing professional development (CPD). 48
18. Executive Committee membership 1991–2011 18. Executive Committee membership 1991–2011 \ Past- Secretary President Vice President Treasurer Member Member Member Member Member President General E. Mutschler D.D. Breimer None P. Sensi S. Agurell K. Nicolics P. Rossignol E. Mutschler D.D. Breimer None P. Sensi S. Agurell K. Nicolics P. Rossignol E. Mutschler D.D. Breimer None P. Sensi S. Agurell Y. Michotte M. Rowland D.D. Breimer M. Rowland E. Mutschler B. Lindeke B. Lindeke Y. Michotte F Pellerin D.D. Breimer M. Rowland E. Mutschler B. Lindeke B. Lindeke Y. Michotte F. Pellerin M Rowland A.Grahnén D.D. Breimer B. Lindeke B. Lindeke A.F. Fell F. Pellerin A.A. Hincal M. Rowland A. Grahnén D.D. Breimer B. Lindeke B. Lindeke A.F. Fell M. Veillard A.A. Hincal M. Rowland A. Grahnén D.D. Breimer B. Lindeke B. Lindeke A.F. Fell M. Veillard A.A. Hincal 1991- 1992 1992- 1993 1993- 1994 1994- 1995 1995- 1996 1996- 1997 1997- 1998 1998- 1999 Secretary Past- President Vice President General Member Member Member Member Member Member President (Ex Officio) M. Rowland A. Grahnén D.D. Breimer B. Lindeke D. Duchêne A.F. Fell M. Veillard A.A. Hincal B. Clement O.J. Bjerrum D. Duchêne O.J. Bjerrum M. Rowland B. Lindeke A. Grahnén R. Paoletti M. Veillard A A.Hincal B. Clement H. de Jong D. Duchêne O.J. Bjerrum M. Rowland H. H. Lindén F. Bühler R. Paoletti M. Veillard A A.Hincal B. Clement H. de Jong 1999- 2000 2000- 2001 2001- 2002 49 Secretary Past- President President-Elect Treasurer General Member Member Member Member Member President (Ex Officio) D. Duchêne O.J. Bjerrum None C. Bogentoft H. H. Lindén R. Paoletti C.R. Noe A. Mrhar B. Clement A. Demirdere O.J. Bjerrum C.R. Noe D. Duchêne C. Bogentoft H. H. Lindén R. Paoletti T. Dingermann A. Mrhar C. Doherty A. Demirdere O.J. Bjerrum C.R. Noe D. Duchêne P. From H. H. Lindén R. Paoletti T. Dingermann H. Köszegi-Szalai C. Doherty D.J.A. Crommelin C.R. Noe D.J.A. Crommelin O.J. Bjerrum P. From H. H. Lindén R. Paoletti T. Dingermann H. Köszegi-Szalai C. Doherty P. Vuorela C.R. Noe D.J.A. Crommelin O.J. Bjerrum P. From H. H. Lindén B. Aksu T. Dingermann H. Köszegi-Szalai C. Doherty P. Vuorela D.J.A. Crommelin P. Vuorela C.R. Noe P. From H. H. Lindén B. Aksu U. Holzgrabe H. Köszegi-Szalai C. Doherty J.A. Guimarães Morais D.J.A. Crommelin P. Vuorela C.R. Noe S. Stegemann H. H. Lindén B. Aksu U. Holzgrabe Vacant C. Doherty J.A. Guimarães Morais C.G. Wilson A. Cuine D.J.A. Crommelin L. Dencker H. H. Lindén B. Aksu U. Holzgrabe R.S. Gaspar E-M. J. Murrey Muchitsch E-M. C.G. Wilson A. Cuine D.J.A. Crommelin L. Dencker H. H. Lindén B. Aksu U. Holzgrabe R.S. Gaspar Muchitsch M. Jadrijević-Mladar Takač 2002- 2003 2003- 2004 2004- 2005 2005- 2006 2006- 2007 2007- 2008 2008- 2009 2009- 2010 2010- 2011
Page 1 and 2: EUFEPS Yearbook 2011 20 th Annivers
Page 3 and 4: cal Sciences 2001 2002 2003 2004 20
Page 6 and 7: Pharma Ingredients & Services Custo
Page 8 and 9: The Gamlen Tablet Press The world
Page 10 and 11: Sustainable sponsorship of EUFEPS g
Page 12 and 13: 2. PRESIDENT’S INTRODUCTION Democ
Page 14 and 15: 4. Member Societies Academy of Phar
Page 16 and 17: Croatian Pharmaceutical Society - C
Page 18 and 19: Hellenic Society of Medicinal Chemi
Page 20 and 21: Norwegian Pharmaceutical Society No
Page 22 and 23: Romanian Society of Pharmaceutical
Page 24 and 25: Swedish Swedish Academy Academy of
Page 26 and 27: 5. Individual Memberships Represent
Page 28 and 29: B. The membership terminates: • i
Page 30 and 31: K. The Executive Director shall •
Page 32 and 33: 7. Executive Committee 2010-2011 EU
Page 34 and 35: 8. Advisory Committees Committee on
Page 36 and 37: 9. EUFEPS Networks Scope and aim Th
Page 38 and 39: Network Environment and Pharmaceuti
Page 40 and 41: 10. Awards and Prizes EUFEPS is, si
Page 42 and 43: The New Safe Medicines Faster Award
Page 44 and 45: 12. The Pharmaceutical Sciences Fai
Page 46 and 47: 14. EUFEPS in EU Projects Since est
Page 48 and 49: 16. EUFEPS on the Global Scene Sinc
Page 52 and 53: Selection of articles from the EUFE
Page 54 and 55: EUFEPS Newsletter, 1992, vol. 1, is
Page 64 and 65: Frankfurt. CIR consists of a core g
Page 66 and 67: Objective 5 To enhance the recognit
Page 68 and 69: that they have reached the conclusi
Page 70 and 71: The procedure is safe and of relati
Page 78 and 79: EUFEPS Newsletter, 2001, vol. 10, i
Page 80 and 81: XXVIII
Page 86 and 87: paradigm shift regarding the qualit
Page 92 and 93: professionals into academia, indust
Page 100 and 101:
EUFEPS Newsletter, 2005, vol. 14, i
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
ecomes an issue’ in Verona (2006)
Page 112 and 113:
on which “Theology, Jurisprudence
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
important steps towards a comprehen
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
and set up their “own” programm
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
show all

2011 Anniversary Yearbook - EUFEPS today and history

Create successful ePaper yourself

Delete template?

Save as template?